{
  "id": 1769614688583,
  "seqId": 118,
  "title": "RETINAL DETACHMENT & BREAKS: THE CLINICAL GUIDE",
  "summary": "An exhaustive clinical reference covering the identification, risk stratification, and surgical management of retinal breaks and posterior vitreous detachment (PVD) based on standard ophthalmic protocols.",
  "date": "2026-01-28T15:38:08.583Z",
  "data": {
    "title": "RETINAL DETACHMENT & BREAKS: THE CLINICAL GUIDE",
    "summary": "An exhaustive clinical reference covering the identification, risk stratification, and surgical management of retinal breaks and posterior vitreous detachment (PVD) based on standard ophthalmic protocols.",
    "summary_illustration": "<svg viewBox='0 0 200 200' xmlns='http://www.w3.org/2000/svg'><circle cx='100' cy='100' r='80' fill='none' stroke='#0056b3' stroke-width='4'/><path d='M40 100 Q 70 50 160 80' fill='none' stroke='#e63946' stroke-width='3'/><circle cx='160' cy='80' r='10' fill='#e63946' opacity='0.6'/><line x1='100' y1='100' x2='155' y2='85' stroke='#0056b3' stroke-dasharray='4'/><text x='70' y='140' font-family='Arial' font-size='12' fill='#0056b3'>Retinal Break</text></svg>",
    "sections": [
      {
        "title": "Posterior Vitreous Detachment (PVD) Visualization",
        "icon": "visibility",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "blue",
        "content": [
          "Fig. 16.16 Posterior vitreous detachment components:",
          "(A) Biomicroscopy showing detached and collapsed gel",
          "(B) Ultrasound B-scan",
          "(C) OCT of posterior pole"
        ]
      },
      {
        "title": "Clinical Features: Timing & Location",
        "icon": "schedule",
        "type": "table",
        "layout": "half_width",
        "color_theme": "green",
        "content": {
          "headers": [
            "Feature",
            "Description"
          ],
          "rows": [
            [
              "Timing",
              "Breaks usually present at or soon after PVD symptoms; 5% delayed by several weeks."
            ],
            [
              "Location",
              "Usually upper retina; more common temporal than nasal."
            ],
            [
              "Macular Breaks",
              "Rare in PVD; usually round in myopic eyes; distinct from age-related macular holes."
            ]
          ]
        }
      },
      {
        "title": "Morphology & Definitions",
        "icon": "biometrics",
        "type": "plain_text",
        "layout": "half_width",
        "color_theme": "purple",
        "content": "Retinal breaks may be flat or associated with a surrounding cuff of SRF (subretinal fluid). If fluid extends more than one disc diameter from the edge of a break, a Retinal Detachment (RD) is said to be present."
      },
      {
        "title": "The Taxonomy of Retinal Breaks (Fig. 16.17)",
        "icon": "category",
        "type": "table",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Type of Break",
            "Key Characteristics",
            "Vitreous Status"
          ],
          "rows": [
            [
              "U-Tears (Horseshoe)",
              "Consist of a flap; apex pulled anteriorly; base remains attached to retina (Fig. 16.17A).",
              "Persistent traction by vitreous."
            ],
            [
              "Operculated Tears",
              "Flap completely torn away leaving a round/oval break (Fig. 16.17B). Operculum suspended in vitreous.",
              "Vitreous gel is detached from the break site."
            ],
            [
              "Retinal Holes",
              "Round or oval; smaller than tears; lower risk of RD (slowly progressive shallow RD in young female myopes). May occur in lattice or paving stone degeneration (atrophic holes - Fig. 16.17C).",
              "PVD not necessarily present; operculum may be visible if separation occurred."
            ],
            [
              "Dialysis",
              "Circumferential tear along ora serrata; usually from blunt trauma. Large peripheral break with rolled edge (Fig. 16.17D).",
              "Vitreous gel remains attached to the posterior margin."
            ],
            [
              "Giant Retinal Tear",
              "Variant of U-tear involving 90° or more of retinal circumference (Fig. 16.17E and F). Located in immediate post-oral retina or equator.",
              "Vitreous gel remains attached to the anterior margin."
            ]
          ]
        }
      },
      {
        "title": "Management Philosophy & Risk Management",
        "icon": "psychology",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "yellow",
        "content": [
          "Management remains imperfectly defined; approaches differ between subspecialists.",
          "Trend: Less aggressive prophylactic treatment for asymptomatic/operculated breaks; focus on observation and education.",
          "Patient Education: Instruct on symptoms of vitreous detachment and RD; provide written information; urge urgent review for new symptoms.",
          "Prophylaxis Risks: Small risk of new break formation or epiretinal membrane formation. Severe complications are rare."
        ]
      },
      {
        "title": "Risk Factors for Progression to Detachment",
        "icon": "trending_up",
        "type": "mindmap",
        "layout": "full_width",
        "color_theme": "red",
        "content": {
          "center": "High Risk of RD",
          "branches": [
            "Miscellaneous: Fellow eye RD, Prior cataract surgery (vitreous loss), Myopia, Family history, Marfan/Stickler/Ehlers–Danlos",
            "Symptoms: Acute PVD symptomatic breaks are higher risk than routine asymptomatic ones",
            "Size: Larger breaks = higher risk",
            "Persistent Traction: U-tears (high) vs. Operculated/Round holes (low)",
            "Shape: U-tears higher risk than round holes",
            "Location: Superior breaks (gravity effect), Superotemporal (threatens macula), Equatorial (higher risk than oral/vitreous base)",
            "Stability Signs: Pigmentation around break indicates chronicity",
            "Lens Status: Aphakia (now rare) confers higher risk"
          ]
        }
      },
      {
        "title": "Clinical Scenarios & Intervention Guide",
        "icon": "clinical_notes",
        "type": "table",
        "layout": "full_width",
        "color_theme": "green",
        "content": {
          "headers": [
            "Scenario",
            "Risk Level",
            "Management Plan"
          ],
          "rows": [
            [
              "Acutely Symptomatic U-Tears",
              "High (90% lead to RD)",
              "Urgent intervention needed (reduces risk to 5%)."
            ],
            [
              "Operculated Tears (Asymptomatic)",
              "Low",
              "Observation safe. Review: 2-4 wks, 1-3 mos, 6-12 mos, then annually. Treat if bridging vessel is present."
            ],
            [
              "Asymptomatic U-Tears",
              "Low (5%)",
              "Observation safe as per operculated tears unless other high-risk factors present."
            ],
            [
              "Traumatic Breaks / Acute Dialysis",
              "Variable",
              "Should always be treated."
            ],
            [
              "Asymptomatic Dialysis",
              "Low",
              "Can sometimes be followed; surgery if RD present."
            ],
            [
              "Asymptomatic Subclinical RD",
              "10% progressive",
              "Case-by-case (e.g., treat large superotemporal; observe small inferior). Informed consent/regular review vital."
            ],
            [
              "Asymptomatic Flat Round Holes",
              "Very Low",
              "No prophylactic treatment; review every 1-2 years."
            ],
            [
              "Pre-Intervention Consideration",
              "Increased Risk",
              "Consider prophylaxis for asymptomatic breaks (inc. atrophic) prior to cataract surgery, laser capsulotomy, or intravitreal injection."
            ]
          ]
        }
      },
      {
        "title": "Critical Clinical Tip",
        "icon": "priority_high",
        "type": "red_flag",
        "layout": "full_width",
        "color_theme": "red",
        "content": [
          "TIP: A patient with a symptomatic retinal break associated with an acute PVD is at risk of RD and needs rapid treatment."
        ]
      },
      {
        "title": "Treatment Techniques: Laser vs. Cryotherapy",
        "icon": "compare",
        "type": "table",
        "layout": "full_width",
        "color_theme": "blue",
        "content": {
          "headers": [
            "Feature",
            "Laser Retinopexy",
            "Cryoretinopexy"
          ],
          "rows": [
            [
              "Optimal Use",
              "Most cases; precise; less collateral damage; lower ERM risk.",
              "Multiple contiguous tears; extensive lesions; hazy media; small pupils."
            ],
            [
              "Access",
              "Slit lamp or BIO; indentation needed for very peripheral lesions.",
              "Requires BIO visualization and indentation; may need conjunctival incision for post-equatorial access."
            ],
            [
              "Anaesthesia",
              "Topical (occasionally regional/general).",
              "Subconjunctival or regional commonly required."
            ],
            [
              "Mechanism",
              "Confluent burns surround lesion (Fig 16.18).",
              "Freeze until whitening; single row of applications (Fig 16.19)."
            ]
          ]
        }
      },
      {
        "title": "Laser Retinopexy Protocol",
        "icon": "bolt",
        "type": "key_point",
        "layout": "half_width",
        "color_theme": "purple",
        "content": [
          "Duration: 0.1 second",
          "Spot Size: 200–300 μm (3-mirror) or 100–200 μm (wide-field)",
          "Power: Starting at 200 mW (adjust for moderate blanching)",
          "BIO Delivery: Adjust spot via condensing lens (usually 20 D)",
          "Pattern: 2-3 rows of confluent burns",
          "Caution: Identify landmarks to avoid macular damage"
        ]
      },
      {
        "title": "Cryoretinopexy Procedure Steps",
        "icon": "ac_unit",
        "type": "process",
        "layout": "half_width",
        "color_theme": "blue",
        "content": [
          "Step 1: Instrument Purge (10 sec @ -25 °C, repeat after 1 min)",
          "Step 2: Set Treatment Temperature (typically -85 °C)",
          "Step 3: Verification (check ice ball in sterile water; 5-mm ball in 10 sec)",
          "Step 4: Indentation and Activation until visible whitening",
          "Step 5: Thawing (2-3 seconds) before moving tip",
          "Step 6: Maintain probe orientation; surround lesion with 1 row"
        ]
      },
      {
        "title": "Post-Treatment Care & Follow-Up",
        "icon": "event_available",
        "type": "key_point",
        "layout": "full_width",
        "color_theme": "green",
        "content": [
          "Post-Cryo: Eye is usually padded; oral analgesia prescribed.",
          "Activity: Avoid strenuous physical exertion for about 1 week until adhesion forms.",
          "Review Schedule: Typically 1–2 weeks after treatment.",
          "Visual Evidence: Pigmentation and chorioretinal atrophy indicate healing (Fig. 16.19)."
        ]
      }
    ],
    "chapterId": "vitreoretinal"
  },
  "chapterId": "vitreoretinal",
  "_newlyImported": 1769614688583,
  "communityId": "sub_1769614237355_vz3gc4iqe",
  "communityAuthor": "Dodi",
  "communityDate": "2026-01-28T15:30:37.356Z",
  "_serverSynced": true
}